Author: alp398

CHDS Faculty Eve Wittenberg is collaborating on a new study on the health-related quality of life of alcohol consumption. Led by investigators at the Bryan School of Business and

CHDS welcomes Jenny Spencer, a postdoctoral fellow in the Training for Oncology Populations Sciences (TOPS) program. Dr. Spencer graduated from the Gilling’s School of Global Public Health

In benefit-cost analysis, fatality risk reductions are usually valued based on estimates of adults’ willingness to pay for changes in their own risks, regardless of whether the risk reduction

CHDS welcomes YuLi (Lily) Hsieh and Mike Eber to the PhD Program in Health Policy decision science track beginning Fall 2019. Yuli (Lily) Hsieh graduated from the

Doctoral candidate John Giardina interned at the Health Decision Sciences Center (HDSC) at Massachusetts General Hospital in Summer, 2019. With funding from a GSAS Graduate

The Center for the Evaluation of Value and Risk in Health at Tufts has announced a webinar on “The State of Global Health Cost-effectiveness Analysis: Insights for Action”. The webinar

This summer, Health Policy PhD student Karen Smith is working as a fellow at the Massachusetts Health Policy Commission (HPC). The HPC is an independent state agency

CHDS Adjunct Professors Uwe Siebert and Maria (Myriam) Hunink return to Boston each summer to teach in the Program in Clinical Effectiveness. Professor

Jin-Tan Liu, a long-term visiting professor at CHDS, was recently awarded a National Chair Professorship by the Taiwan Ministry of Education. National Chair Professorships

In an essay in the Wall Street Journal, “The Best Investment I Ever Made,” Bill Gates reports that his and Melinda’s investments in Gavi, the Global Fund, and the Global Polio Eradication Initiative